FDA Signals Broader Shift in How Hormone Therapy Is Regulated

FDA Signals Broader Shift in How Hormone Therapy Is Regulated

PBS News
Published on: 13/08/2026

Coverage of the wider US regulatory shift on hormone therapy labelling, with health officials describing the changes as a move toward more current, evidence-based prescribing guidance rather than decades-old warnings.

In the News
Read more
US Health Regulators Move to Ease Restrictions on Testosterone Therapy

US Health Regulators Move to Ease Restrictions on Testosterone Therapy

Bloomberg
Published on: 13/08/2026

In June 2026, the US Department of Health and Human Services directed the FDA to remove long-standing warning labels from testosterone products prescribed for age-related decline, citing updated safety evidence and aiming to give doctors clearer guid

In the News
Read more